About CHO-SPN
CHO-SPN is a Healthcare company based in Mumbai (India) founded in 1990. It manufactures pharmaceutical products, supplies drugs, and researches life sciences globally. It operates on a B2B model. Its Indian entity Cho-Spn Lifescience And Research Private Limited reported revenue of ₹7.5 Lakh. CHO-SPN offers products and services including Tablets, Injections, Liquid Syrup, and Eye/Ear Drops. Its focus areas include Research and Development, Life Sciences, Pharmaceuticals and Drug Manufacturing. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
CHO-SPN Life Science Research Pvt. Ltd. is a pharmaceutical company based in Mumbai, India, that manufactures and supplies various drugs including tablets, injections, syrups, and eye drops. It focuses on research and development in life sciences, applying advances in molecular biology to develop medicines for life-threatening conditions. The company exports products internationally and engages in drug innovation, serving healthcare providers and distributors through B2B channels.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Website chospn.com
- Legal Name Cho-Spn Lifescience And Research Private Limited
- Date of Incorporation 17 Oct, 1990
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹7.5 Lakh
FY 2024 · +123% YoY
- Net Profit₹5.2 Lakh
FY 2024 · 69% margin
- EBITDA₹7.1 Lakh
FY 2024 · 94% margin
Associated legal entities of CHO-SPN
CHO-SPN operates through Cho-Spn Lifescience And Research Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cho-Spn Lifescience And Research Private Limited CIN U73100MH1990PTC058586 | Active | 17 Oct 1990 | Mumbai, Maharashtra | ₹0.1 Cr | 2 | View details |
Products & Services of CHO-SPN
CHO-SPN offers a comprehensive portfolio of products and services, including Tablets, Injections, Liquid Syrup, and Eye/Ear Drops.
Medicines in tablet form for treating various health conditions.
Injectable drugs used for administering treatments effectively.
Syrup formulations for oral medication and symptom relief.
Topical drops for eye and ear treatments and infections.
Board of directors of Cho-Spn Lifescience And Research Private Limited (CHO-SPN)
Cho-Spn Lifescience And Research Private Limited is the primary company behind CHO-SPN. The board of Cho-Spn Lifescience And Research Private Limited currently have 2 directors; the longest-serving is Kirti Talakshi Shah, appointed in 1991. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kirti Talakshi Shah DIN 00250253 | Director | 28 Feb 1991 | 35 yrs 8 mo | Cho-Spn Lifescience And Research Private Limited |
| Keyur Ratanshi Shah DIN 03395448 | Director | 21 Aug 2023 | 3 yrs 2 mo | Cho-Spn Lifescience And Research Private Limited |
Financials of CHO-SPN
Figures of Cho-Spn Lifescience And Research Private Limited, the primary company behind CHO-SPN, for FY 2024. Revenue was ₹7.5 Lakh (+123% year on year). Net profit was ₹5.2 Lakh (69% margin). EBITDA was ₹7.1 Lakh (94% margin). Revenue has grown at a compounded annual rate of +22% over three years and -18% over five years.
- ₹7.5 LakhRevenue · FY 2024 · +123% YoY
- ₹5.2 LakhNet profit · 69% margin
- ₹7.1 LakhEBITDA · 94% margin
- ₹2.5 LakhPaid-up capital
- +22%Revenue CAGR, 3 years
- -18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cho-Spn Lifescience And Research Private Limited are on its company page.
Detailed financial statements for CHO-SPN
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to CHO-SPN
CHO-SPN has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of CHO-SPN
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CHO-SPN
CHO-SPN was founded in 1990.
CHO-SPN is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind CHO-SPN, Cho-Spn Lifescience And Research Private Limited, reported revenue of ₹7.5 Lakh for FY 2024, up 123% year on year.
CHO-SPN Life Science Research Pvt. Ltd. is a pharmaceutical company based in Mumbai, India, that manufactures and supplies various drugs including tablets, injections, syrups, and eye drops. It focuses on research and development in life sciences, applying advances in molecular biology to develop medicines for life-threatening conditions. The company exports products internationally and engages in drug innovation, serving healthcare providers and distributors through B2B channels.
CHO-SPN's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
CHO-SPN offers Tablets, Injections, Liquid Syrup, and Eye/Ear Drops.
CHO-SPN operates through Cho-Spn Lifescience And Research Private Limited.
The legal entities of CHO-SPN currently have 2 directors, including Keyur Ratanshi Shah, Kirti Talakshi Shah.